Centessa Pharmaceuticals (CNTA) Stock Chart & Stock Price History $13.75 +0.14 (+1.06%) As of 10:52 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Centessa Pharmaceuticals Stock Price Performance 5 Day Performance+0.32%1 Month Performance+17.76%3 Month Performance-20.22%6 Month Performance-14.04%Year-To-Date Performance-17.89%1 Year Performance+45.24% Receive CNTA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Centessa Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address CNTA Stock Chart for Monday, May, 5, 2025 CNTA Chart by TradingView Centessa Pharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/02/2025$13.50$13.61+0.81%$14.39$13.49749,858 shs$1.81 billion05/01/2025$13.71$13.50-1.53%$14.06$13.15622,716 shs$1.80 billion04/30/2025$13.72$13.71-0.07%$13.95$13.35553,595 shs$1.83 billion04/29/2025$13.75$13.72-0.22%$14.00$13.47483,400 shs$1.83 billion04/28/2025$13.79$13.75-0.29%$14.08$13.52756,600 shs$1.83 billion04/25/2025$13.61$13.79+1.32%$14.05$13.44480,936 shs$1.84 billion04/24/2025$13.03$13.61+4.45%$13.66$12.89538,958 shs$1.81 billion04/23/2025$12.67$13.03+2.84%$13.50$12.85566,016 shs$1.74 billion04/22/2025$12.15$12.67+4.28%$13.03$12.10568,831 shs$1.69 billion04/21/2025$12.30$12.15-1.22%$12.40$11.95635,477 shs$1.62 billion Get the Latest News and Ratings for CNTA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Centessa Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 04/18/2025$12.30$12.30$12.30$11.87784,645 shs$1.64 billion04/17/2025$11.83$12.30+3.97%$12.30$11.87784,645 shs$1.64 billion04/16/2025$11.94$11.83-0.92%$12.11$11.50787,733 shs$1.58 billion04/15/2025$11.94$11.94$12.82$11.75594,432 shs$1.59 billion04/14/2025$11.57$11.94+3.20%$12.14$11.50766,062 shs$1.59 billion04/11/2025$11.27$11.57+2.66%$11.72$10.87635,858 shs$1.54 billion04/10/2025$11.76$11.27-4.17%$11.78$10.451.33 million shs$1.50 billion04/09/2025$10.71$11.76+9.80%$12.34$9.603.16 million shs$1.57 billion04/09/2025$10.71$11.76+9.80%$12.34$9.603.16 million shs$1.57 billion04/08/2025$11.28$10.71-5.05%$12.39$10.511.23 million shs$1.43 billion04/08/2025$11.28$10.71-5.05%$12.39$10.511.23 million shs$1.43 billion04/07/2025$11.68$11.28-3.42%$11.86$10.581.45 million shs$1.50 billion04/04/2025$13.06$11.68-10.57%$12.76$11.391.58 million shs$1.54 billion Related Companies LNTH Stock Price Chart BBIO Stock Price Chart TGTX Stock Price Chart LEGN Stock Price Chart SRPT Stock Price Chart TLX Stock Price Chart ADMA Stock Price Chart BPMC Stock Price Chart VRNA Stock Price Chart NUVL Stock Price Chart Receive CNTA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Centessa Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CNTA) was last updated on 5/5/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredMan who predicted $100K Bitcoin sees a huge run coming for another coin …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Centessa Pharmaceuticals plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Centessa Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CNTA Stock Free CNTA Stock Alerts